Plain-English translation of NCT06810583 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Leukemia research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a medication called to see if it can help prevent serious bacterial infections in children and young adults receiving intensive treatment for leukemia. During leukemia treatment, the immune system becomes very weak and vulnerable to life-threatening infections. Researchers want to know if this medication — given as an injection every 28 days along with an oral antibiotic — works better or as well as the antibiotics doctors currently use to protect patients.
Children undergoing leukemia treatment often develop dangerously low white blood cell counts, making them highly vulnerable to severe infections that can be life-threatening. Doctors currently use certain antibiotics to prevent these infections, but this trial is exploring whether this medication might be a safer or more effective option.
You likely qualify if…
You likely don't qualify if…
You would receive injections of the medication once every 28 days for up to 12 weeks, along with oral antibiotic pills that you take at home. You'll have blood samples drawn before your first injection and before each follow-up injection so doctors can monitor how the medication works in your body. You'll also provide a stool sample at the beginning. Throughout the trial, the study team will watch carefully for any side effects from the new medication and track whether you develop any bloodstream infections.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States